PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DXC vs. BRK-B
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DXC and BRK-B is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

DXC vs. BRK-B - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in DXC Technology Company (DXC) and Berkshire Hathaway Inc. (BRK-B). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
3.64%
7.82%
DXC
BRK-B

Key characteristics

Sharpe Ratio

DXC:

-0.22

BRK-B:

2.06

Sortino Ratio

DXC:

-0.04

BRK-B:

2.87

Omega Ratio

DXC:

1.00

BRK-B:

1.37

Calmar Ratio

DXC:

-0.10

BRK-B:

3.61

Martin Ratio

DXC:

-0.59

BRK-B:

8.71

Ulcer Index

DXC:

14.72%

BRK-B:

3.47%

Daily Std Dev

DXC:

39.70%

BRK-B:

14.70%

Max Drawdown

DXC:

-90.12%

BRK-B:

-53.86%

Current Drawdown

DXC:

-77.83%

BRK-B:

-3.13%

Fundamentals

Market Cap

DXC:

$3.73B

BRK-B:

$1.01T

EPS

DXC:

$0.18

BRK-B:

$50.02

PE Ratio

DXC:

113.78

BRK-B:

9.36

PEG Ratio

DXC:

0.28

BRK-B:

10.06

Total Revenue (TTM)

DXC:

$9.86B

BRK-B:

$276.52B

Gross Profit (TTM)

DXC:

$1.65B

BRK-B:

$48.42B

EBITDA (TTM)

DXC:

$1.09B

BRK-B:

$98.94B

Returns By Period

In the year-to-date period, DXC achieves a 2.50% return, which is significantly lower than BRK-B's 3.24% return.


DXC

YTD

2.50%

1M

-0.58%

6M

6.44%

1Y

-10.96%

5Y*

-10.02%

10Y*

N/A

BRK-B

YTD

3.24%

1M

3.25%

6M

7.33%

1Y

27.51%

5Y*

15.38%

10Y*

12.16%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DXC vs. BRK-B — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DXC
The Risk-Adjusted Performance Rank of DXC is 3434
Overall Rank
The Sharpe Ratio Rank of DXC is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of DXC is 3131
Sortino Ratio Rank
The Omega Ratio Rank of DXC is 3131
Omega Ratio Rank
The Calmar Ratio Rank of DXC is 3939
Calmar Ratio Rank
The Martin Ratio Rank of DXC is 3434
Martin Ratio Rank

BRK-B
The Risk-Adjusted Performance Rank of BRK-B is 9292
Overall Rank
The Sharpe Ratio Rank of BRK-B is 9393
Sharpe Ratio Rank
The Sortino Ratio Rank of BRK-B is 9191
Sortino Ratio Rank
The Omega Ratio Rank of BRK-B is 8989
Omega Ratio Rank
The Calmar Ratio Rank of BRK-B is 9696
Calmar Ratio Rank
The Martin Ratio Rank of BRK-B is 9090
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DXC vs. BRK-B - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for DXC Technology Company (DXC) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for DXC, currently valued at -0.22, compared to the broader market-2.000.002.004.00-0.222.06
The chart of Sortino ratio for DXC, currently valued at -0.04, compared to the broader market-4.00-2.000.002.004.006.00-0.042.87
The chart of Omega ratio for DXC, currently valued at 1.00, compared to the broader market0.501.001.502.001.001.37
The chart of Calmar ratio for DXC, currently valued at -0.10, compared to the broader market0.002.004.006.00-0.103.61
The chart of Martin ratio for DXC, currently valued at -0.58, compared to the broader market-10.000.0010.0020.0030.00-0.598.71
DXC
BRK-B

The current DXC Sharpe Ratio is -0.22, which is lower than the BRK-B Sharpe Ratio of 2.06. The chart below compares the historical Sharpe Ratios of DXC and BRK-B, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-0.22
2.06
DXC
BRK-B

Dividends

DXC vs. BRK-B - Dividend Comparison

Neither DXC nor BRK-B has paid dividends to shareholders.


TTM20242023202220212020201920182017
DXC
DXC Technology Company
0.00%0.00%0.00%0.00%0.00%0.82%2.18%24.79%0.83%
BRK-B
Berkshire Hathaway Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

DXC vs. BRK-B - Drawdown Comparison

The maximum DXC drawdown since its inception was -90.12%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for DXC and BRK-B. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-77.83%
-3.13%
DXC
BRK-B

Volatility

DXC vs. BRK-B - Volatility Comparison

DXC Technology Company (DXC) has a higher volatility of 10.13% compared to Berkshire Hathaway Inc. (BRK-B) at 4.55%. This indicates that DXC's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
10.13%
4.55%
DXC
BRK-B

Financials

DXC vs. BRK-B - Financials Comparison

This section allows you to compare key financial metrics between DXC Technology Company and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab